|
Re: OTC Expert & Grey Market Restrictions
|
1
|
Zenith Epigenetics
|
Nov 22, 2022 04:05PM
|
|
Re: Looking forward now , can/will management use this meeting as the start of many positive updates?
|
3
|
Resverlogix Corp.
|
Aug 24, 2022 03:49PM
|
|
Re: Down Memory Lane
|
3
|
Resverlogix Corp.
|
May 25, 2022 01:17PM
|
|
Re: Managing Covid Expectations
|
1
|
Resverlogix Corp.
|
May 09, 2022 08:58PM
|
|
Re: Market Woes
|
5
|
Resverlogix Corp.
|
May 02, 2022 08:04PM
|
|
Re: BTD
|
3
|
Resverlogix Corp.
|
Apr 27, 2022 10:12AM
|
|
Re: Resverlogix Announces One-Year Extension of Debenture
|
2
|
Resverlogix Corp.
|
Apr 21, 2022 05:01PM
|
|
Re: Exempt Distribution - 2022-04-14
|
4
|
Resverlogix Corp.
|
Apr 21, 2022 04:54PM
|
|
Re: Sachs conference with Bioasis
|
2
|
BIOASIS TECHNOLOGIES INC
|
Mar 24, 2022 02:56PM
|
|
Re: OTC Trading questions
|
5
|
Zenith Epigenetics
|
Mar 07, 2022 08:38AM
|
|
Re: OTC Trading questions
|
2
|
Zenith Epigenetics
|
Mar 05, 2022 08:48AM
|
|
Study results?
|
9
|
Resverlogix Corp.
|
Mar 05, 2022 08:42AM
|
|
Re: https://themarkether...
|
1
|
Resverlogix Corp.
|
Feb 23, 2022 02:11PM
|
|
Debenture questions.
|
6
|
Resverlogix Corp.
|
Feb 17, 2022 12:44PM
|
|
Re: Epigenetics
|
5
|
Resverlogix Corp.
|
Feb 14, 2022 10:54AM
|
|
Re: a new study that one researcher called "stunning."
|
5
|
Resverlogix Corp.
|
Feb 11, 2022 02:26PM
|
|
Re: Shenzhen Hepalink-Warrants Expiration
|
1
|
Resverlogix Corp.
|
Feb 07, 2022 04:49PM
|
|
Re: Shenzhen Hepalink-Warrants Expiration
|
2
|
Resverlogix Corp.
|
Feb 07, 2022 04:47PM
|
|
Re: Gonna be a multi billion dollar company soon imo get on board
|
4
|
Resverlogix Corp.
|
Feb 03, 2022 12:45PM
|
|
Re: New video quietly released
|
9
|
Resverlogix Corp.
|
Jan 29, 2022 02:09PM
|
